You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original research
Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022205589205576952
Dec 202270867089143
Jan 20231604159665
Feb 20231359135681
Mar 202316511658102
Apr 20231042104383
May 202378278353
Jun 20231416141350
Jul 20231539153656
Aug 20231508151063
Sep 20231355135281
Oct 20231076107858
Nov 202346746757
Dec 202331631752
Jan 202424023467
Feb 202421521552
Mar 2024190190148
Apr 202416016060
May 202418317560
Jun 202411010436
Jul 202412611546
Aug 2024929075
Total2281062280572440